newsfilter
← Latest News
GlobeNewswire·

Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement

DOYLESTOWN, Pa., April 01, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a clinical-stage precision medicine oncology company focused on the discovery and development of